These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 15620579

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Absence of expression of transforming growth factor-beta type II receptor is associated with an aggressive growth pattern in a murine renal carcinoma cell line, Renca.
    Kundu SD, Kim IY, Zelner D, Janulis L, Goodwin S, Engel JD, Lee C.
    J Urol; 1998 Nov; 160(5):1883-8. PubMed ID: 9783979
    [Abstract] [Full Text] [Related]

  • 3. Reversion of transcriptional repression of Sp1 by 5 aza-2' deoxycytidine restores TGF-beta type II receptor expression in the pancreatic cancer cell line MIA PaCa-2.
    Venkatasubbarao K, Ammanamanchi S, Brattain MG, Mimari D, Freeman JW.
    Cancer Res; 2001 Aug 15; 61(16):6239-47. PubMed ID: 11507078
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer.
    Zhao H, Shiina H, Greene KL, Li LC, Tanaka Y, Kishi H, Igawa M, Kane CJ, Carroll P, Dahiya R.
    Cancer; 2005 Jul 01; 104(1):44-52. PubMed ID: 15895377
    [Abstract] [Full Text] [Related]

  • 6. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV, Gama P, Wen X, Demopoulos R, Munger JS, Carcangiu ML, Reiss M, Gold LI.
    Cancer Res; 2002 May 15; 62(10):2778-90. PubMed ID: 12019154
    [Abstract] [Full Text] [Related]

  • 7. Transforming growth factor-beta type II receptor confers tumor suppressor activity in murine renal carcinoma (Renca) cells.
    Engel JD, Kundu SD, Yang T, Lang S, Goodwin S, Janulis L, Cho JS, Chang J, Kim SJ, Lee C.
    Urology; 1999 Jul 15; 54(1):164-70. PubMed ID: 10414746
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Trichostatin A-induced TGF-beta type II receptor expression in retinoblastoma cell lines.
    Kashiwagi Y, Horie K, Kanno C, Inomata M, Imamura T, Kato M, Yamamoto T, Yamashita H.
    Invest Ophthalmol Vis Sci; 2010 Feb 15; 51(2):679-85. PubMed ID: 19737884
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of transforming growth factor-beta-insensitive mouse Renca tumor by transforming growth factor-beta elimination.
    Perry K, Wong L, Liu V, Park I, Zhang Q, Rejen V, Huang X, Smith ND, Jovanovic B, Lonning S, Teicher BA, Lee C.
    Urology; 2008 Jul 15; 72(1):225-9. PubMed ID: 18295867
    [Abstract] [Full Text] [Related]

  • 12. Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency.
    Periyasamy S, Ammanamanchi S, Tillekeratne MP, Brattain MG.
    Oncogene; 2000 Sep 21; 19(40):4660-7. PubMed ID: 11030155
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line.
    Okamoto M, Oyasu R.
    Cell Growth Differ; 1997 Aug 21; 8(8):921-6. PubMed ID: 9269901
    [Abstract] [Full Text] [Related]

  • 14. Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine.
    Ammanamanchi S, Kim SJ, Sun LZ, Brattain MG.
    J Biol Chem; 1998 Jun 26; 273(26):16527-34. PubMed ID: 9632722
    [Abstract] [Full Text] [Related]

  • 15. Role of transforming growth factor (TGF)-beta Type I and TGF-beta type II receptors in the TGF-beta1-regulated gene expression in pituitary prolactin-secreting lactotropes.
    Sarkar DK, Pastorcic M, De A, Engel M, Moses H, Ghasemzadeh MB.
    Endocrinology; 1998 Aug 26; 139(8):3620-8. PubMed ID: 9681516
    [Abstract] [Full Text] [Related]

  • 16. Characterization of TGF-beta-regulated interleukin-8 expression in human prostate cancer cells.
    Lu S, Dong Z.
    Prostate; 2006 Jun 15; 66(9):996-1004. PubMed ID: 16541418
    [Abstract] [Full Text] [Related]

  • 17. Expression of transforming growth factor-beta receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells.
    Ko Y, Banerji SS, Liu Y, Li W, Liang J, Soule HD, Pauley RJ, Willson JK, Zborowska E, Brattain MG.
    J Cell Physiol; 1998 Aug 15; 176(2):424-34. PubMed ID: 9648930
    [Abstract] [Full Text] [Related]

  • 18. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y, Kyprianou N.
    Cancer Res; 1999 Mar 15; 59(6):1366-71. PubMed ID: 10096572
    [Abstract] [Full Text] [Related]

  • 19. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G, Schwarz RE, Higgins L, McEnroe G, Chakravarty S, Dugar S, Reiss M.
    Cancer Res; 2004 Aug 01; 64(15):5200-11. PubMed ID: 15289325
    [Abstract] [Full Text] [Related]

  • 20. Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III.
    Deng X, Bellis S, Yan Z, Friedman E.
    Cell Growth Differ; 1999 Jan 01; 10(1):11-8. PubMed ID: 9950213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.